These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1098 related articles for article (PubMed ID: 29329595)
1. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro. Liu B; Ding F; Hu D; Zhou Y; Long C; Shen L; Zhang Y; Zhang D; Wei G Stem Cell Res Ther; 2018 Jan; 9(1):7. PubMed ID: 29329595 [TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction. Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820 [TBL] [Abstract][Full Text] [Related]
3. Exosomes released by human umbilical cord mesenchymal stem cells protect against renal interstitial fibrosis through ROS-mediated P38MAPK/ERK signaling pathway. Liu B; Hu D; Zhou Y; Yu Y; Shen L; Long C; Butnaru D; Timashev P; He D; Lin T; Xu T; Zhang D; Wei G Am J Transl Res; 2020; 12(9):4998-5014. PubMed ID: 33042402 [TBL] [Abstract][Full Text] [Related]
4. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction. Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407 [TBL] [Abstract][Full Text] [Related]
5. Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways. Wang Z; Chen Z; Li B; Zhang B; Du Y; Liu Y; He Y; Chen X Pharm Biol; 2020 Dec; 58(1):828-837. PubMed ID: 32866059 [TBL] [Abstract][Full Text] [Related]
6. Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways. Li R; Guo Y; Zhang Y; Zhang X; Zhu L; Yan T Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30836660 [TBL] [Abstract][Full Text] [Related]
7. Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction. da Silva AF; Silva K; Reis LA; Teixeira VP; Schor N Cell Transplant; 2015; 24(12):2657-66. PubMed ID: 25695732 [TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition. Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510 [TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro. Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303 [TBL] [Abstract][Full Text] [Related]
10. Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy. Li A; Zhang X; Shu M; Wu M; Wang J; Zhang J; Wang R; Li P; Wang Y Phytomedicine; 2017 Jul; 30():28-41. PubMed ID: 28545667 [TBL] [Abstract][Full Text] [Related]
11. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis. Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599 [TBL] [Abstract][Full Text] [Related]
12. Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction. Jiang GT; Chen X; Li D; An HX; Jiao JD Mol Med Rep; 2014 Sep; 10(3):1501-8. PubMed ID: 24926571 [TBL] [Abstract][Full Text] [Related]
13. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21. Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B Nephron; 2022; 146(1):110-120. PubMed ID: 34724669 [TBL] [Abstract][Full Text] [Related]
14. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo. Liu P; Li F; Qiu M; He L Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085 [TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury. Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411 [TBL] [Abstract][Full Text] [Related]
16. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling. Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016 [TBL] [Abstract][Full Text] [Related]
17. Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation. Hassan NME; Said E; Shehatou GSG Life Sci; 2021 May; 272():119241. PubMed ID: 33600861 [TBL] [Abstract][Full Text] [Related]
18. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis. Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-derived microparticles ameliorate peritubular capillary rarefaction via inhibition of endothelial-mesenchymal transition and decrease tubulointerstitial fibrosis in unilateral ureteral obstruction. Choi HY; Lee HG; Kim BS; Ahn SH; Jung A; Lee M; Lee JE; Kim HJ; Ha SK; Park HC Stem Cell Res Ther; 2015 Mar; 6(1):18. PubMed ID: 25889661 [TBL] [Abstract][Full Text] [Related]